Oliver Mowforth

Receptor tyrosine kinase targeted therapies in glioblastoma: a systematic review

Introduction Glioblastoma is the most common primary central nervous system malignancy and has a median survival of 14.6 months. Receptor tyrosine kinase (RTKs) signalling consitutes one of the three major pathways driving glioblastoma, implicating them as a therapeutic target. H...

Toward the Optimal Way to Assess Symptomatic Fatigue in Degenerative Cervical Myelopathy: Mixed Methods Survey Study

Background Recent work has demonstrated that individuals with degenerative cervical myelopathy (DCM) often experience symptoms of fatigue that are underrepresented in the literature. Conversely, understanding fatigue is highly important to people living with DCM. The AO Spine REC...